Lack of association between lipoprotein(a) and coronary artery calcification in the genetic epidemiology network of arteriopathy (GENOA) study

Iftikhar Jan Kullo, Kent R Bailey, Lawrence F. Bielak, Patrick F. Sheedy, George G. Klee, Sharon L. Kardia, Patricia A. Peyser, Eric Boerwinkle, Stephen T Turner

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

OBJECTIVE: To investigate the relationship between lipoprotein(a) [Lp(a)] levels and the extent of coronary atherosclerosis in a cohort that consisted predominantly of hypertensive patients. PATIENTS AND METHODS: Patients were ascertained through sibships that contained at least 2 individuals with essential hypertension diagnosed before the age of 60 years. The 10-year coronary heart disease (CHD) risk was estimated on the basis of the Framingham risk equation. Serum Lp(a) was measured by an immunoturbidlmetric assay. Coronary artery calcification (CAC) was measured noninvasively by electron beam computed tomography and CAC score calculated using the Agatston score. RESULTS: Patients included 765 non-Hispanic, white individuals (59% women) participating in the Genetic Epidemiology Network of Arteriopathy study. The mean ± SD age of the patients was 62±8 years, and 77% had hypertension. The prevalence of detectable CAC was 87% in men and 60% in women. The CAC scores did not differ significantly across quintiles of Lp(a) levels in either men or women. In a multiple regression model that included conventional risk factors, Lp(a) levels were not related to CAC quantity in either sex. No significant interactions were noted between Lp(a) levels and the conventional risk factors in the prediction of CAC quantity. When stratified on the basis of the 10-year CHD risk, 26.5% of the patients were low risk (<6%), 60.5% were intermediate risk (60%-20%), and 12.9% were high risk (>20%). Lipoprotein(a) was not associated with CAC quantity within subgroups based on 10-year CHD risk. CONCLUSION: In this cohort enriched with hypertensive patients, the estimated 10-year CHD risk did not appear to modify the lack of an association between Lp(a) levels and CAC.

Original languageEnglish (US)
Pages (from-to)1258-1263
Number of pages6
JournalMayo Clinic Proceedings
Volume79
Issue number10
StatePublished - 2004

Fingerprint

Lipoprotein(a)
Molecular Epidemiology
Coronary Vessels
Coronary Disease
X Ray Computed Tomography
Coronary Artery Disease
Hypertension
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lack of association between lipoprotein(a) and coronary artery calcification in the genetic epidemiology network of arteriopathy (GENOA) study. / Kullo, Iftikhar Jan; Bailey, Kent R; Bielak, Lawrence F.; Sheedy, Patrick F.; Klee, George G.; Kardia, Sharon L.; Peyser, Patricia A.; Boerwinkle, Eric; Turner, Stephen T.

In: Mayo Clinic Proceedings, Vol. 79, No. 10, 2004, p. 1258-1263.

Research output: Contribution to journalArticle

Kullo, Iftikhar Jan ; Bailey, Kent R ; Bielak, Lawrence F. ; Sheedy, Patrick F. ; Klee, George G. ; Kardia, Sharon L. ; Peyser, Patricia A. ; Boerwinkle, Eric ; Turner, Stephen T. / Lack of association between lipoprotein(a) and coronary artery calcification in the genetic epidemiology network of arteriopathy (GENOA) study. In: Mayo Clinic Proceedings. 2004 ; Vol. 79, No. 10. pp. 1258-1263.
@article{9a1eefa012244896841fdacd000d05ef,
title = "Lack of association between lipoprotein(a) and coronary artery calcification in the genetic epidemiology network of arteriopathy (GENOA) study",
abstract = "OBJECTIVE: To investigate the relationship between lipoprotein(a) [Lp(a)] levels and the extent of coronary atherosclerosis in a cohort that consisted predominantly of hypertensive patients. PATIENTS AND METHODS: Patients were ascertained through sibships that contained at least 2 individuals with essential hypertension diagnosed before the age of 60 years. The 10-year coronary heart disease (CHD) risk was estimated on the basis of the Framingham risk equation. Serum Lp(a) was measured by an immunoturbidlmetric assay. Coronary artery calcification (CAC) was measured noninvasively by electron beam computed tomography and CAC score calculated using the Agatston score. RESULTS: Patients included 765 non-Hispanic, white individuals (59{\%} women) participating in the Genetic Epidemiology Network of Arteriopathy study. The mean ± SD age of the patients was 62±8 years, and 77{\%} had hypertension. The prevalence of detectable CAC was 87{\%} in men and 60{\%} in women. The CAC scores did not differ significantly across quintiles of Lp(a) levels in either men or women. In a multiple regression model that included conventional risk factors, Lp(a) levels were not related to CAC quantity in either sex. No significant interactions were noted between Lp(a) levels and the conventional risk factors in the prediction of CAC quantity. When stratified on the basis of the 10-year CHD risk, 26.5{\%} of the patients were low risk (<6{\%}), 60.5{\%} were intermediate risk (60{\%}-20{\%}), and 12.9{\%} were high risk (>20{\%}). Lipoprotein(a) was not associated with CAC quantity within subgroups based on 10-year CHD risk. CONCLUSION: In this cohort enriched with hypertensive patients, the estimated 10-year CHD risk did not appear to modify the lack of an association between Lp(a) levels and CAC.",
author = "Kullo, {Iftikhar Jan} and Bailey, {Kent R} and Bielak, {Lawrence F.} and Sheedy, {Patrick F.} and Klee, {George G.} and Kardia, {Sharon L.} and Peyser, {Patricia A.} and Eric Boerwinkle and Turner, {Stephen T}",
year = "2004",
language = "English (US)",
volume = "79",
pages = "1258--1263",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "10",

}

TY - JOUR

T1 - Lack of association between lipoprotein(a) and coronary artery calcification in the genetic epidemiology network of arteriopathy (GENOA) study

AU - Kullo, Iftikhar Jan

AU - Bailey, Kent R

AU - Bielak, Lawrence F.

AU - Sheedy, Patrick F.

AU - Klee, George G.

AU - Kardia, Sharon L.

AU - Peyser, Patricia A.

AU - Boerwinkle, Eric

AU - Turner, Stephen T

PY - 2004

Y1 - 2004

N2 - OBJECTIVE: To investigate the relationship between lipoprotein(a) [Lp(a)] levels and the extent of coronary atherosclerosis in a cohort that consisted predominantly of hypertensive patients. PATIENTS AND METHODS: Patients were ascertained through sibships that contained at least 2 individuals with essential hypertension diagnosed before the age of 60 years. The 10-year coronary heart disease (CHD) risk was estimated on the basis of the Framingham risk equation. Serum Lp(a) was measured by an immunoturbidlmetric assay. Coronary artery calcification (CAC) was measured noninvasively by electron beam computed tomography and CAC score calculated using the Agatston score. RESULTS: Patients included 765 non-Hispanic, white individuals (59% women) participating in the Genetic Epidemiology Network of Arteriopathy study. The mean ± SD age of the patients was 62±8 years, and 77% had hypertension. The prevalence of detectable CAC was 87% in men and 60% in women. The CAC scores did not differ significantly across quintiles of Lp(a) levels in either men or women. In a multiple regression model that included conventional risk factors, Lp(a) levels were not related to CAC quantity in either sex. No significant interactions were noted between Lp(a) levels and the conventional risk factors in the prediction of CAC quantity. When stratified on the basis of the 10-year CHD risk, 26.5% of the patients were low risk (<6%), 60.5% were intermediate risk (60%-20%), and 12.9% were high risk (>20%). Lipoprotein(a) was not associated with CAC quantity within subgroups based on 10-year CHD risk. CONCLUSION: In this cohort enriched with hypertensive patients, the estimated 10-year CHD risk did not appear to modify the lack of an association between Lp(a) levels and CAC.

AB - OBJECTIVE: To investigate the relationship between lipoprotein(a) [Lp(a)] levels and the extent of coronary atherosclerosis in a cohort that consisted predominantly of hypertensive patients. PATIENTS AND METHODS: Patients were ascertained through sibships that contained at least 2 individuals with essential hypertension diagnosed before the age of 60 years. The 10-year coronary heart disease (CHD) risk was estimated on the basis of the Framingham risk equation. Serum Lp(a) was measured by an immunoturbidlmetric assay. Coronary artery calcification (CAC) was measured noninvasively by electron beam computed tomography and CAC score calculated using the Agatston score. RESULTS: Patients included 765 non-Hispanic, white individuals (59% women) participating in the Genetic Epidemiology Network of Arteriopathy study. The mean ± SD age of the patients was 62±8 years, and 77% had hypertension. The prevalence of detectable CAC was 87% in men and 60% in women. The CAC scores did not differ significantly across quintiles of Lp(a) levels in either men or women. In a multiple regression model that included conventional risk factors, Lp(a) levels were not related to CAC quantity in either sex. No significant interactions were noted between Lp(a) levels and the conventional risk factors in the prediction of CAC quantity. When stratified on the basis of the 10-year CHD risk, 26.5% of the patients were low risk (<6%), 60.5% were intermediate risk (60%-20%), and 12.9% were high risk (>20%). Lipoprotein(a) was not associated with CAC quantity within subgroups based on 10-year CHD risk. CONCLUSION: In this cohort enriched with hypertensive patients, the estimated 10-year CHD risk did not appear to modify the lack of an association between Lp(a) levels and CAC.

UR - http://www.scopus.com/inward/record.url?scp=4644241902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644241902&partnerID=8YFLogxK

M3 - Article

C2 - 15473406

AN - SCOPUS:4644241902

VL - 79

SP - 1258

EP - 1263

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 10

ER -